Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis
Biomarker-informed approaches incorporating inflammatory markers, cortisol levels, cognitive status, and symptom clustering may further refine patient selection and optimize therapeutic outcomes
Insulin, for example, controls blood sugar levels and helps break down foods into energy
Change one amino acid, cleave one bond, oxidize one residue, and the entire three-dimensional structure shifts
As a result, they are now emerging as promising drug candidates for the treatment of epilepsy